Dimethyladenine

Dimethyladenine

SCHEMBL1997329

CN(C)c1ncnc2nc[nH]c12.OC[C@H]1OC[C@H](O)[C@@H]1O

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 2/20 0.57
HSP90AA1 P07900 2/20 0.57
CHEK1 O14757 1/20 0.57
AURKA O14965 1/20 0.57
PDPK1 O15530 1/20 0.57
CHEK2 O96017 1/20 0.57
HSP90AB1 P08238 1/20 0.57
PRKACA P17612 1/20 0.57
CCNE1 P24864 1/20 0.57
MARK3 P27448 1/20 0.57
RPS6KA3 P51812 1/20 0.57
PRKCD Q05655 1/20 0.57
LRRK2 Q5S007 1/20 0.57
MARK2 Q7KZI7 1/20 0.57
HSD17B10 Q99714 3/20 0.49
HTT P42858 8/20 0.42
MAP3K5 Q99683 1/20 0.42
EGFR P00533 1/20 0.41
CSF1R P07333 1/20 0.41
NCOA1 Q15788 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL98133 0.85 HSD17B10 (0.38) CDK2HSP90AA1CHEK1AURKAPDPK1
Hypoxanthine SCHEMBL4367641 0.83 LMNA (0.39) CDK2CHEK1PDPK1LRRK2HSD17B10
SCHEMBL9396874 0.83 HTT (0.36) CDK2HSP90AA1CHEK1AURKAPDPK1
Dimethyladenine SCHEMBL10617856 0.82 CDK2 (0.61) CDK2HSP90AA1CHEK1AURKAPDPK1
Adenine SCHEMBL593934 0.82 PI4KA (0.54) CDK2CHEK1PDPK1LRRK2HSD17B10
SCHEMBL9142303 0.82 LMNA (0.38) CDK2CHEK1PDPK1LRRK2HSD17B10
Mercaptopurine Anhydrous SCHEMBL1998389 0.82 LMNA (0.38) CDK2CHEK1PDPK1LRRK2HSD17B10
SCHEMBL4202116 0.82 CYP3A4 (0.45) CDK2HSD17B10HTTSMN1; SMN2LMNA
Dimethyladenine SCHEMBL152594 0.75 LRRK2 (1.00) CDK2HSP90AA1CHEK1AURKAPDPK1
Dimethyladenine SCHEMBL29349831 0.75 LRRK2 (1.00) CDK2HSP90AA1CHEK1AURKAPDPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2516637-B1 THERMOSTABLE BIOCATALYST COMBINATION FOR NUCLEOSIDE SYNTHESIS PLASMIA BIOTECH S L (ES) 2016-04-20 EP disclosed
US-8759034-B2 Thermostable biocatalyst combination for nucleoside synthesis PLASMIA BIOTECH, S.L. (ES) 2014-06-24 US disclosed
US-20130337547-A1 THERMOSTABLE BIOCATALYST COMBINATION FOR NUCLEOSIDE SYNTHESIS BRILL ENGINES, S.L. (ES) 2013-12-19 US disclosed
US-8512997-B2 Thermostable biocatalyst combination for nucleoside synthesis PLASMIA BIOTECH, S.L. (ES) 2013-08-20 US disclosed
EP-2516637-A1 THERMOSTABLE BIOCATALYST COMBINATION FOR NUCLEOSIDE SYNTHESIS Plasmia Biotech, S.L. (ES) 2012-10-31 EP disclosed
US-20120264175-A1 THERMOSTABLE BIOCATALYST COMBINATION FOR NUCLEOSIDE SYNTHESIS BRILL ENGINES, S.L. (ES) 2012-10-18 US disclosed
WO-2011076894-A1 THERMOSTABLE BIOCATALYST COMBINATION FOR NUCLEOSIDE SYNTHESIS INSTITUT UNIV. DE CIÈNCIA I TECNOLOGIA, S.A. (ES) 2011-06-30 WO disclosed
EP-2338985-A1 Thermostable biocatalyst combination for nucleoside synthesis Institut Univ. de Ciència i Tecnologia, s.a. (ES) 2011-06-29 EP disclosed